MRI in breast cancer management: Potential for benefit and harm

International Journal of Fertility and Women's Medicine

Volumn 50, Issue 6, 2005, Pages 281-284

  Jatoi, Ismail ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

BRCA 1; BRCA 2; Breast cancer; Mammography; MRI

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER SURGERY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMAGING; INTERMETHOD COMPARISON; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCREENING; BREAST TUMOR; FEMALE; GENETICS; MASS SCREENING; METHODOLOGY; PATHOLOGY; PATIENT SELECTION; REVIEW; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; PATIENT SELECTION;

EID: 33645898956     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gore J: Out of the shadows-MRI and the Nobel Prize. N Engl J Med 349:2290-2292, 2003.
2. Hylton N: Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 23:1678-1684, 2005.
3. Jatoi I: Breast cancer screening. Am J Surg 177: 518-524, 1999.
4. Kerlikowske K: Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 22:79-86, 1997.
5. Thomas DB, Gao DL, Ray RM, et al: Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 94:1445-1457, 2002.
6. Semiglazov VF, Moiseyenko VM, Manikhas AG: Role of breast self-examination in early detection of breast cancer. Russia/WHO prospective randomized trial in St. Petersburg. Cancer Strategy 1:144-151, 1999.
7. Liberman L: Breast cancer screening with MRI-what are the data for patients at high risk? N Engl J Med 351:497-500, 2004.
8. Robson ME, Offit K: Breast MRI for women with hereditary cancer risk. JAMA 292:1368-1370, 2004.
9. Rebbeck TR, Lynch HT, Neuhausen SL, et al: Prophylactic oophorectomy in carriers of BRCA-1 or BRCA-2 mutations. N Engl J Med 346:1616-1622, 2002.
10. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA-1 and BRCA-2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004.
11. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, et al: First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63:53-60, 2000.
12. Stoutjesdijk MJ, Boetes C, Jager CJ, et al: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93:1095-1102, 2001.
13. Kuhl CK, Schrading S, Leutner CC, et al: Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer: first mid-term results of a multi-modality clinical screening trial (abstract). PIOC Am Soc Clin Oncol 22:2, 2003.
14. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004.
15. Vaidya JS, Baum M. Benefits and risks of screening mammography in women with BRCA-1 and BRCA-2 mutations. JAMA 278:290, 1997.
16. Henry-Tillman RS, Harms SE, Westbrook KC, et al: Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 178:496-500, 1999.
17. Bagley FH: The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg 139:380-383, 2004.